With 70% of medical decisions influenced by diagnostic test results, supply chain disruptions don’t just delay shipments, they can delay diagnoses, treatment decisions, and patient care.
Resilinc CEO, Kamal Ahluwalia and Roche Diagnostics’ Ruben Munoz-Aguilera will share how they are navigating strict regulatory oversight, single-source technical components, cold chain dependencies, and geopolitical volatility.